Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects

@article{Turul2006ComparisonOT,
  title={Comparison of two forms of continuous combined hormone replacement therapy with respect to metabolic effects},
  author={Semih Tuğrul and Gazi Yıldırım and Oya Pekin and H{\"u}samettin Uslu and Tayfun Kutlu and Sadiye Eren},
  journal={Archives of Gynecology and Obstetrics},
  year={2006},
  volume={275},
  pages={335-339}
}
ObjectiveTo compare the metabolic effects of two frequently used continuous hormone replacement therapies.Materials and methodsTwo hundred and forty-six menopausal women, aged between 41 and 57 years were enrolled in the present study. They were randomized to receive either estrogen + 2.5 mg medroxyprogesterone acetate (CEE/MPA) or 1 mg 17 estradiol + 0.5 mg norethindrone acetate (E2/NETA). Women in group I (n = 139) and group II (n = 107) were followed up for 1 year and compared with respect… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause

MG Shlipak, JA Simon, +5 authors SB Hulley
  • JAMA
  • 2000
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL

Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?

  • Climacteric : the journal of the International Menopause Society
  • 1998
VIEW 1 EXCERPT

Randomized trial of estrogen plus progestin for secondary prevention of coronary hearth disease in postmenopausal women

A Basta, A Szczudrawa, A Sempka, W Peszek
  • JAMA
  • 1998